Trial halted early: Two-Pill attack on breast cancer brain tumors
NCT ID NCT04791384
Summary
This study tested whether taking two oral medications, abemaciclib and elacestrant, together could help control breast cancer that had spread to the brain. It was designed for post-menopausal women with a specific type of breast cancer (HR+/HER2-) whose cancer had progressed in the brain despite prior treatments. The trial was terminated early after enrolling only 5 participants, so the full results are unknown.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Care Northwest
Spokane Valley, Washington, 99216, United States
-
Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, 33140, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.